[Other] Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia

DrNefario Post time 3 day(s) ago | Show all posts |Read mode
Reward20points

journal:Expert Review of Pharmacoeconomics & Outcomes Research

Authors:Pieralessandro Lasalvia; Yaneth Gil-Rojas; Angel García

Published date:2022-8-18

DOI:10.1080/14737167.2022.2044310

PDF link:https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2044310

Article link:http://dx.doi.org/10.1080/14737167.2022.2044310

Article Source:Informa UK Limited


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply3 Show all posts
George Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Georgee Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

George Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    21565

Latest Reply

Return to the list